ResearcherWashington University in St. LouisNo recent work listed

Lauren K. Park

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-2656-762X; OpenAlex author ID A5076284932. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for pa… Co-author DOI 10.1186/s40170-023-00306-2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

William G. Hawkins · 1 shared paper, 2023 · strength 0.14
- Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2 ↗
Linda R. Peterson · 1 shared paper, 2023 · strength 0.14
- Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2 ↗
Joseph E. Ippolito · 1 shared paper, 2023 · strength 0.14
- Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2 ↗
Kian‐Huat Lim · 1 shared paper, 2023 · strength 0.14
- Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.